Intestinal alpha-glucosidase and alpha-amylase

Intestinal alpha-glucosidases and alpha-amylase are key enzymes responsible for the breakdown of dietary carbohydrates into absorbable monosaccharides. Pancreatic alpha-amylase is secreted into the small intestine to hydrolyze complex starch into maltose and malto-oligosaccharides [1]. Subsequently, alpha-glucosidases such as sucrase-isomaltase and maltase-glucoamylase, located on the intestinal brush border, further break these down into glucose [2]. These enzymes are significant therapeutic targets for treating type 2 diabetes mellitus because their activity directly influences postprandial blood glucose levels [3]. Alpha-glucosidase inhibitors, such as acarbose, miglitol, and voglibose, competitively inhibit these enzymes to slow the rate of carbohydrate digestion and glucose absorption [1,4]. By delaying glucose entry into the systemic circulation, these drugs help prevent sharp postprandial hyperglycemic spikes [3]. This mechanism is particularly useful for managing patients with high postprandial glucose levels who do not achieve targets with other medications [1]. However, the presence of undigested carbohydrates in the distal small intestine and colon often leads to fermentation by bacteria, resulting in side effects like flatulence and osmotic diarrhea [1]. Sources: [1] StatPearls: Alpha-Glucosidase Inhibitors (https://www.ncbi.nlm.nih.gov/books/NBK557848/) [2] UniProt: Maltase-glucoamylase (O43451) and Sucrase-isomaltase (P14410) [3] PubMed: Alpha-glucosidase inhibitors for patients with type 2 diabetes (https://pubmed.ncbi.nlm.nih.gov/15846640/) [4] PubChem: Acarbose (CID 41774)

Other names

Intestinal glycoside hydrolasesCarbohydrate-digesting enzymesAlpha-glucosidaseAlpha-amylaseMaltase-glucoamylaseSucrase-isomaltasePancreatic alpha-amylase

Competitive inhibition of intestinal brush-border alpha-glucosidases and pancreatic alpha-amylase, delaying the hydrolysis of complex carbohydrates into glucose and reducing postprandial glycemic excursions.